Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Avenue Therapeutics
(NASDAQ:ATXI)
Intraday
$6.47
6.353
[5429.91%]
After-Hours
$6.47
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$6.47
6.353
[5429.91%]
At close: Apr 26
$6.47
0
[0.00%]
After Hours: 5:47PM EDT
Get Report
Watch
Avenue Therapeutics Inc recently split on Friday, April 26, 2024 with a ratio of 1:75
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Avenue Therapeutics Stock (NASDAQ:ATXI)
Avenue Therapeutics Stock (NASDAQ: ATXI)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, April 26, 2024
Avenue Therapeutics shares are trading lower. The company recently announced a 1-for-75 reverse stock split of its common stock.
Benzinga Newsdesk
-
3 hours ago
Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
-
4 hours ago
Thursday, April 25, 2024
Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending
Benzinga Newsdesk
-
22 hours ago
Wednesday, April 24, 2024
Crude Oil Moves Lower; B. Riley Financial Shares Jump
Avi Kapoor
-
2 days ago
Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
-
2 days ago
Dow Dips Over 100 Points; Ribbon Communications Shares Spike Higher
Avi Kapoor
-
2 days ago
Why Avenue Therapeutics (ATXI) Shares Are Getting Hammered
Henry Khederian
-
2 days ago
Nasdaq Rises 0.5%; Tesla Shares Jump After Q1 Results
Avi Kapoor
-
2 days ago
Avenue Therapeutics shares are trading lower after the company announced a reverse stock split.
Benzinga Newsdesk
-
2 days ago
Avenue Therapeutics Plans To Effect 1-For-75 Reverse Split Of Its Issued And Outstanding Common Stock
Benzinga Newsdesk
-
2 days ago
Tuesday, April 09, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
-
Apr 9, 2024, 4:31PM
Monday, March 18, 2024
CORRECTION: Avenue Therapeutics FY23 EPS $(0.98) Vs $(1.63) YoY
Benzinga Newsdesk
-
Mar 18, 2024, 4:16PM
Friday, March 15, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
-
Mar 15, 2024, 5:33PM
Avenue Therapeutics Receives Listing Determination from Nasdaq
Benzinga Newsdesk
-
Mar 15, 2024, 8:15AM
Monday, March 11, 2024
Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
-
Mar 11, 2024, 1:41PM
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
-
Mar 11, 2024, 9:05AM
Why Fangdd Network Group Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Mar 11, 2024, 8:08AM
Avenue Therapeutics to Present BAER-101 Preclinical Data At American Society For Experimental Neurotherapeutics 2024 Annual Meeting Mar. 13
Benzinga Newsdesk
-
Mar 11, 2024, 8:01AM
Thursday, February 22, 2024
Avenue Therapeutics Publishes In Drug Development Research Regarding First-In-Class Preclinical Data Of BAER-101 In Translational Model Of Absence Epilepsy
Benzinga Newsdesk
-
Feb 22, 2024, 8:49AM
Thursday, January 11, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Jan 11, 2024, 4:31PM
Friday, January 05, 2024
Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
-
Jan 5, 2024, 1:13PM
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Jan 5, 2024, 12:31PM
Why Avenue Therapeutics Shares Are Getting Hammered
Henry Khederian
-
Jan 5, 2024, 10:01AM
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
-
Jan 5, 2024, 8:05AM
Why Dermata Therapeutics Shares Are Trading Higher By Over 57%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Jan 5, 2024, 8:03AM
Thursday, January 04, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Jan 4, 2024, 4:31PM
Crude Oil Moves Lower; Walgreens Posts Upbeat Earnings
Avi Kapoor
-
Jan 4, 2024, 2:15PM
Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
-
Jan 4, 2024, 1:37PM
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
-
Jan 4, 2024, 12:31PM
Dow Surges 200 Points; US Services PMI Edges Higher In December
Avi Kapoor
-
Jan 4, 2024, 12:00PM
US Stocks Mixed; Jobless Claims Fall To 202,000
Avi Kapoor
-
Jan 4, 2024, 9:48AM
Avenue Therapeutics shares are trading higher after the company announced it reached a final agreement with the FDA for the Phase 3 safety study for IV tramadol.
Benzinga Newsdesk
-
Jan 4, 2024, 9:22AM
Avenue Therapeutics Reaches Final Agreement with FDA For Phase 3 Safety Study For IV Tramadol
Benzinga Newsdesk
-
Jan 4, 2024, 8:33AM
Tuesday, January 02, 2024
Avenue Therapeutics Announced That All Patients Have Been Enrolled In The Phase 1b/2a Clinical Trial Of AJ201 For The Treatment Of Spinal And Bulbar Muscular Atrophy, Kennedy's Disease
Benzinga Newsdesk
-
Jan 2, 2024, 8:34AM
Tuesday, December 12, 2023
Why Icosavax Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Dec 12, 2023, 8:00AM
Monday, December 11, 2023
Maxim Group Initiates Coverage On Avenue Therapeutics with Buy Rating, Announces Price Target of $0.75
Benzinga Newsdesk
-
Dec 11, 2023, 9:43AM
Friday, December 01, 2023
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
-
Dec 1, 2023, 8:06AM
Thursday, November 30, 2023
Why Salesforce Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Nov 30, 2023, 8:01AM
Wednesday, November 29, 2023
Why Patterson Companies Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
-
Nov 29, 2023, 2:02PM
Why Workday Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Nov 29, 2023, 8:11AM
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
Nov 29, 2023, 8:06AM
Robert Davidow Reported A14.5 % Passive Stake In Avenue Therapeutics In A 13G Filing Tuesday; Shares Up 60% Premarket
Charles Gross
-
Nov 29, 2023, 5:05AM
Monday, November 27, 2023
Why UP Fintech Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Nov 27, 2023, 8:10AM
Friday, November 24, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
-
Nov 24, 2023, 4:31PM
Monday, November 13, 2023
Avenue Therapeutics Q3 EPS $0.06 Up From $(0.45) YoY
Benzinga Newsdesk
-
Nov 13, 2023, 5:35PM
Avenue Therapeutics Cash Position As Of Sept. 30 $200K
Benzinga Newsdesk
-
Nov 13, 2023, 5:16PM
Thursday, November 02, 2023
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
-
Nov 2, 2023, 9:05AM
Tuesday, October 31, 2023
Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
-
Oct 31, 2023, 1:36PM
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
Oct 31, 2023, 1:31PM
Avenue Therapeutics shares are trading lower after the company announced the pricing of a $5 million public offering.
Benzinga Newsdesk
-
Oct 31, 2023, 11:29AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch